1. Home
  2. TBPH vs ASM Comparison

TBPH vs ASM Comparison

Compare TBPH & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$18.73

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Logo Avino Silver & Gold Mines Ltd. (Canada)

ASM

Avino Silver & Gold Mines Ltd. (Canada)

HOLD

Current Price

$5.55

Market Cap

798.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBPH
ASM
Founded
2013
1968
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
993.7M
798.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TBPH
ASM
Price
$18.73
$5.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$27.80
$5.27
AVG Volume (30 Days)
601.0K
4.2M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
476.57
EPS
0.58
0.14
Revenue
$80,327,000.00
$86,065,000.00
Revenue This Year
$70.78
$38.58
Revenue Next Year
N/A
$39.81
P/E Ratio
$32.19
$41.24
Revenue Growth
27.12
58.42
52 Week Low
$7.90
$0.85
52 Week High
$20.33
$6.67

Technical Indicators

Market Signals
Indicator
TBPH
ASM
Relative Strength Index (RSI) 58.73 62.30
Support Level $18.39 $5.19
Resistance Level $20.32 $5.72
Average True Range (ATR) 0.87 0.31
MACD -0.05 0.13
Stochastic Oscillator 53.71 81.43

Price Performance

Historical Comparison
TBPH
ASM

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About ASM Avino Silver & Gold Mines Ltd. (Canada)

Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.

Share on Social Networks: